A Qualitative Study of the Experiences of Living With Multiple Myeloma.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Oncology Nursing Society Country of Publication: United States NLM ID: 7809033 Publication Model: Print Cited Medium: Internet ISSN: 1538-0688 (Electronic) Linking ISSN: 0190535X NLM ISO Abbreviation: Oncol Nurs Forum Subsets: MEDLINE
    • Publication Information:
      Publication: Pittsburgh, PA : Oncology Nursing Society
      Original Publication: New York, Oncology Nursing Society.
    • Subject Terms:
      Multiple Myeloma*/therapy; Humans ; Qualitative Research ; Southeastern United States
    • Abstract:
      Purpose: To explore the ways in which multiple myeloma affects an individual's life in the modern treatment era.
      Participants & Setting: 15 individuals with multiple myeloma and 10 clinicians were recruited from two academic medical centers in the southeastern United States.
      Methodologic Approach: Semistructured interviews were conducted with individuals with multiple myeloma and clinicians to explore the effect of a multiple myeloma diagnosis and treatment on individuals' lives. Transcribed interviews were analyzed using conventional content analysis.
      Findings: The following four themes emerged from the analysis.
      Implications for Nursing: The treatment journey for those with multiple myeloma can be lifelong and may require frequent visits to an oncologist and, potentially, many successive lines of therapy. Life effects are far-reaching and long-term. Nurses should be aware of the interprofessional resources to help meet these individuals' needs. With thorough assessment, care planning, and education, nurses can play a key role in mitigating the negative effects of multiple myeloma and its treatment.
    • References:
      J Cancer Surviv. 2016 Oct;10(5):865-73. (PMID: 26995006)
      Lancet. 2005 Jan 1-7;365(9453):82-93. (PMID: 15639683)
      Qual Life Res. 2020 Jun;29(6):1419-1431. (PMID: 31848847)
      Eur J Haematol. 2017 Jul;99(1):3-17. (PMID: 28322018)
      Am Soc Clin Oncol Educ Book. 2016;35:e418-23. (PMID: 27249749)
      Palliat Support Care. 2006 Dec;4(4):365-87. (PMID: 17133896)
      Support Care Cancer. 2011 Jan;19(1):101-11. (PMID: 19998045)
      Leuk Lymphoma. 2016 Dec;57(12):2827-2832. (PMID: 27104965)
      Eur J Cancer. 2007 Sep;43(14):2093-9. (PMID: 17627811)
      Blood. 2014 Nov 13;124(20):3043-51. (PMID: 25293776)
      Eur J Cancer Care (Engl). 2011 Mar;20(2):267-75. (PMID: 20950368)
      Blood Adv. 2017 Jan 4;1(4):282-287. (PMID: 29296944)
      Expert Rev Hematol. 2017 Oct;10(10):933-939. (PMID: 28885063)
      JAMA. 1995 Jan 4;273(1):59-65. (PMID: 7996652)
      J Clin Nurs. 2018 Apr;27(7-8):1713-1721. (PMID: 29266501)
      Blood Cancer J. 2017 Mar 24;7(3):e545. (PMID: 28338672)
      Qual Health Res. 2005 Nov;15(9):1277-88. (PMID: 16204405)
      Eur J Haematol. 2016 Nov;97(5):416-429. (PMID: 27528496)
      CA Cancer J Clin. 2020 Jan;70(1):7-30. (PMID: 31912902)
      Curr Hematol Malig Rep. 2018 Apr;13(2):114-124. (PMID: 29450683)
      Blood. 2020 Aug 20;136(8):936-945. (PMID: 32325490)
      JAMA. 2019 May 28;321(20):2025-2027. (PMID: 31135837)
      J Natl Compr Canc Netw. 2018 Jan;16(1):11-20. (PMID: 29295877)
      J Clin Oncol. 2020 Feb 1;38(4):316-322. (PMID: 31804864)
      Palliat Med. 2019 Feb;33(2):123-134. (PMID: 30488781)
      Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):518-524. (PMID: 29222300)
      Lung Cancer. 2019 May;131:69-77. (PMID: 31027701)
      Blood Cancer J. 2018 Feb 28;8(3):26. (PMID: 29531285)
      Can Oncol Nurs J. 2008 Summer;18(3):141-51. (PMID: 18856174)
      Nurs Stand. 2011 Mar 16-22;25(28):38-44. (PMID: 21488448)
      Nat Rev Clin Oncol. 2017 Aug;14(8):461-462. (PMID: 28607521)
      J Pain Symptom Manage. 2019 Dec;58(6):1113-1118. (PMID: 31326505)
      JAMA. 2019 Jan 22;321(3):288-300. (PMID: 30667505)
      Cancer. 2015 Mar 1;121(5):758-65. (PMID: 25369293)
      Curr Cancer Drug Targets. 2017;17(9):846-857. (PMID: 28201976)
      Eur J Oncol Nurs. 2016 Aug;23:51-8. (PMID: 27456375)
      Clin J Oncol Nurs. 2016 Dec 1;20(6 Suppl):S8-S16. (PMID: 27857275)
      J Pain. 2017 Jun;18(6):664-672. (PMID: 28131700)
      Am Soc Clin Oncol Educ Book. 2018 May 23;38:662-666. (PMID: 30231405)
      Mol Cancer. 2019 Nov 5;18(1):154. (PMID: 31684964)
      Surg Oncol Clin N Am. 2018 Apr;27(2):235-242. (PMID: 29496087)
    • Grant Information:
      F31 NR018576 United States NR NINR NIH HHS
    • Contributed Indexing:
      Keywords: multiple myeloma; quality of life; survival; symptom burden; treatment
    • Publication Date:
      Date Created: 20210218 Date Completed: 20210917 Latest Revision: 20210917
    • Publication Date:
      20240105
    • Accession Number:
      PMC8114830
    • Accession Number:
      10.1188/21.ONF.151-160
    • Accession Number:
      33600390